Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The role of endogenous antiradical protective system in multiple sclerosis.
Low dose naltrexone for induction of remission in Crohn's disease.
MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS.
1,25-Dihydroxyvitamin D3 Facilitates M2 Polarization and Upregulates TLR10 Expression on Human Microglial Cells.
Novel 3D analysis of Claudin-5 reveals significant endothelial heterogeneity among CNS microvessels.
Extracting quantitative measures from EAP: a small clinical study using BFOR.
Cyclophosphamide therapy in pediatric multiple sclerosis.
[Neuromyelitis optica.]
Fingolimod protects cultured cortical neurons against excitotoxic death.
Relapsing-remitting multiple sclerosis and chronic idiopathic neutropenia: a challenging combination.
Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS.
Epidemiology of neuromyelitis optica in the world: a systematic review and meta-analysis.
Neurodegeneration and Neuroprotection in Multiple Sclerosis.
Motor vehicle operation in the setting of multiple sclerosis with myelopathy: assessment, adaptive equipment, counseling, and cessation of driving.
Combined treatment with minocycline and prednisone attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.
Levofloxacin-Induced Delirium in a Patient Suffering from Schizoaffective Disorder and Multiple Sclerosis.
Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis.
Coping strategies and mood profiles in patients with multiple sclerosis.
UCSF Neuroimmunology Research Seminar
Tamoxifen Promotes Axonal Preservation and Gait Locomotion Recovery after Spinal Cord Injury in Cats.
Immune cells after prolonged Natalizumab therapy: implications for effectiveness and safety.
Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study.
Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis.
Systematic localization of common disease-associated variation in regulatory DNA.
Mice devoid of tau have increased susceptibility to neuronal damage in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
212
213
214
215
216
217
218
219
220
…
next ›
last »